Pfizer

Open: 31.32 Close: 31.18 Change: -0.14

You'll be sorry if you don't use an AI to decide whether to invest in Pfizer.

Are looking for the most relevant information about Pfizer? Investor spend a lot of time searching for information to make investment decisions in Pfizer. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, product, sale, say, COVID19, decline, and the most common words in the summary are: pfizer, best, vaccine, dose, covid19, credit, year, . One of the sentences in the summary was: Pfizer-BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer reported third-quarter revenue of $13.23 billion, down 42% from the same period a year ago. Pfizer-BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) Pfizer lost more than $2 billion in the third quarter.

Today's News

Pfizer Layoffs confirmed as vaccine manufacturer drives for cost savings. Pfizer announced it will be downsizing its operations in New Jersey, and layoffs will happen as a result. The pharmaceutical giants third-quarter results reflected a poor showing for Covid vaccine sales. Pfizer reported third-quarter revenue of $13.23 billion, down 42% from the same period a year ago. Pfizer said it recorded a $5.6 billion charge for inventory write-offs in the third quarter due to lower-than-expected use of Covid products. That decline in demand also led Pfizer to announce a sweeping $3. Pfizer urged investors to focus on growth in non-COVID products such as the new RSV vaccine Abrysvo. Pfizer slashed $9 billion off its 2023 sales forecast after agreeing to take back nearly 8 million Paxlovid treatment courses from the U.S. Pfizer is still going to be under pressure to meet its sales guidance for 2023. Pfizer-BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) on lower demand for the COVID-19 vaccine made with Pfizer. Pfizer and Moderna say they have sent out millions of doses of the new vaccines in the past week. Pfizer-BioNTech series: Children who received 1 or 2 doses of Pfizer’s COVID-19 vaccine for ages 6 months–4 years, 0.3 mL/3 ug (yellow cap; yellow label) are recommended to receive updated (2023­–2024 Formula) Pfizers COVINE. Pfizer Inc. markets closed S&Pures 4,00 -8.00 -69.00 (-0.00%) Dow Futures 34,55 -6900 (-3.00) Nasdaq Futures 1,21050 -22%, Russell 2000 futures 1,981 -0.42%) Crude Crude Oil 8048 -034 (0.48%) + + + Pfizer Inc. Reports Third-Quarter 2023 Results. Third-quarter revenues for antiviral treatment Paxlovid dropped 97% operationally compared with the prior-year period. EU Antitrust Regulators clear Pfizers $43B acquisition of Seagen. Pfizer axes 200 jobs in Michigan amid covid cost-cutting spree. Pfizer blamed the job cuts on “lower-than-expected utilization for COVID-19 products Pfizer and Moderna have said they are pricing each vaccine dose at over $100. Pfizer laying off 200 in Portage, citing COVID product sales decline. Pfizer lost more than $2 billion in the third quarter, the Associated Press reported earlier this week. Company says decline in COVID-19 products forcing it to make changes.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, product, sale, say, COVID19, decline, and the most common words in the summary are: pfizer, best, vaccine, dose, covid19, credit, year, . One of the sentences in the summary was: Pfizer-BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) Pfizer lost more than $2 billion in the third quarter.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #best #vaccine #dose #covid19 #credit #year.